NovoCure
Novocure is a global oncology company pioneering Tumor Treating Fields (TTFields) therapy, a non-invasive, electric field treatment that disrupts cancer cell division. Its flagship products, Optune Gio and Optune Lua, are approved for glioblastoma (GBM), mesothelioma, and non-small cell lung cancer (NSCLC). Novocure focuses on extending survival in aggressive, hard-to-treat cancers.
